1162900006: Product containing only amivantamab in parenteral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\...

\Epidermal growth factor receptor antagonist antineoplastic agent\Amivantamab-containing product\...

\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

\Amivantamab only product\Amivantamab only product in parenteral dose form

\Protein-tyrosine kinase inhibitor-containing product\Amivantamab-containing product\...

\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

\Amivantamab only product\Amivantamab only product in parenteral dose form

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Amivantamab-containing product\...

\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

\Amivantamab only product\Amivantamab only product in parenteral dose form

\Medicinal product categorised by therapeutic role\Antineoplastic agent\...

\Monoclonal antibody antineoplastic agent\Amivantamab-containing product\...

\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

\Amivantamab only product\Amivantamab only product in parenteral dose form

\Epidermal growth factor receptor antagonist antineoplastic agent\Amivantamab-containing product\...

\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

\Amivantamab only product\Amivantamab only product in parenteral dose form

\Product manufactured as parenteral dose form\Amivantamab-containing product in parenteral dose form\Amivantamab only product in parenteral dose form

Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4592033010 Product containing only amivantamab in parenteral dose form (medicinal product form) en Fully specified name Active Case insensitive SNOMED CT core

4592034016 Amivantamab only product in parenteral dose form en Synonym Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Amivantamab only product in parenteral dose form	Is a	Amivantamab only product	true	Inferred relationship	Some
Amivantamab only product in parenteral dose form	Is a	Amivantamab-containing product in parenteral dose form	true	Inferred relationship	Some
Amivantamab only product in parenteral dose form	Has manufactured dose form	Parenteral dose form	true	Inferred relationship	Some
Amivantamab only product in parenteral dose form	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Some
Amivantamab only product in parenteral dose form	Has active ingredient	Amivantamab	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets